K2 Medical Research, Llc

Maitland, Florida 32751

5 studies enrolling now · 15 studies all time

What they study most

Advanced Parkinson's Disease, Alzheimer Disease, Alzheimer's Disease, Alzheimers Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Early Alzheimer's Disease, Early Preclinical Alzheimer's Disease, PARKINSON DISEASE (Disorder), Parkinson Disease, Preclinical Alzheimer's Disease, Respiratory Syncytial Virus Infections

Studies at this site

• Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD — Recruiting now
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — Recruiting now
• A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease — Recruiting now
• SAD Study in Patients With Parkinson's Disease and Motor Fluctuations — Recruiting now
• A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Recruiting now
• A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects — Stopped early
• Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease — Running, not enrolling
• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling
• An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — Completed
• A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD) — Stopped early
• Alzheimer's Plasma Extension — Running, not enrolling
• MVA-BN-RSV Vaccine Trial — Stopped early